The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

Director South Punjab Pakistan Bait-ul-Mal (PBM) Rana Ramzan Tahir chaired a meeting with assistant directors from the ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

Iowa lawmakers introduce bills to stop Pharmacy Benefit Managers from giving pharmacies less money than it costs to fill prescriptions.

GRAND JUNCTION, Colo. (KJCT) -A bipartisan bill was introduced into the house this week regarding healthcare costs for Coloradans. The bill introduced by Representatives Kyle Brown and Dusty Johnson ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

According to the survey cited by NCPA, 60.4% of independent pharmacists are considering not stocking one or more of the first ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...

Indiana governor's address sparks strong reactions, with GOP strategist praising new ideas and Democratic analyst voicing ...